LIFE Study: Entresto TM in Advanced Heart Failure

Recruiting

18 years - 100 years

All

Phase 3

20 participants needed

1 Location

Brief description of study

This study aims to understand the benefits/risks of Entresto in NYHA III-IV patients.

Detailed description of study

Follow up visits include taking study drug (Entresto vs Valsartan), blood work, physical exam, questionnaires, 6 min walk tests, and medication review.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Entresto,heart failure,end stage,blood pressure,heart disease,ejection fraction,cardiology,heart
Age: 18 years - 100 years
Gender: All

Updated on 04 Aug 2024. Study ID: 825912

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Brief description of study

Detailed description of study

Eligibility of study

Find a site

Interested in the study